NIH-funded research R01 grant

Understanding how germ cells maintain their unique identity

Official title: Protecting and Sustaining Germ Cell Identity

Funded at Whitehead Institute for Biomedical Res · NIH-11084566 · Data updated 2026-11-12

This study is looking at how special cells called germ cells keep their unique abilities to become any type of cell in the body, which could help us understand more about their role in health and development.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWhitehead Institute for Biomedical Res
NIH-funded
Lab location1 site (Cambridge, United States)
Project startAugust 11, 2023
Project endApril 30, 2028
Funding year2025
Award (this year)$419,250
NIH project number5R01HD110546-03
Project IDNIH-11084566 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals interested in reproductive health or those affected by conditions related to germ cell function.

Less likely to help

Patients with no interest in reproductive health or those not affected by germ cell-related conditions may not benefit from this research.

What this research studies

This research investigates the molecular mechanisms that allow germ cells to maintain their unique identity and potential to develop into any cell type in the body. By examining the gene expression programs in primordial germ cells, the study aims to identify key regulators that protect germ cells from reverting to other cell types. The approach includes advanced techniques like single-cell RNA sequencing to gain insights into how these cells function over long periods. This research could provide valuable information on germ cell biology and its implications for human health.

Why it matters

Potential benefit: If successful, this research could lead to breakthroughs in understanding fertility and the development of certain tumors.

How similar studies have gone: Previous research has shown promising results in understanding germ cell biology, but this specific approach is novel and aims to fill existing gaps in knowledge.

Where this research is happening

  • Whitehead Institute for Biomedical Res
    Cambridge, United States
    Active

Researchers

  • Principal investigator: Lehmann, Ruth — Whitehead Institute for Biomedical Res
  • Study coordinator: Lehmann, Ruth

Related research

Other NIH-funded projects on the same topics.

  • Illuminating the dark proteome to fight cancer

    A research program aims to map and understand mysterious dark proteome proteins in cancer and to develop pre-clinical therapies that target them.

    NIH research Whitehead Institute for Biomedical Res · Cambridge, United States · NIH-11516315

  • Center for Genome Editing and Recording: Next-Generation Genome and Epigenome Tools for Disease

    A research center is developing ultra-precise genome and epigenome editing tools to better understand and treat human diseases, with a focus on how genetic variants influence disease and how to safely modify them.

    NIH research Whitehead Institute for Biomedical Res · Cambridge, United States · NIH-11412455

  • Understanding how polyamines work in human cells (a potential cancer focus)

    Researchers are studying how small molecules called polyamines help cancer-related cell growth and survival, with new ways to measure them inside living cells.

    NIH research Whitehead Institute for Biomedical Res · Cambridge, United States · NIH-11398143

  • Delivering therapeutic macromolecules with cell-derived bioparticles

    A researcher aims to safely and efficiently deliver big therapeutic molecules into human cells using cell-derived bioparticles to help treat diseases.

    NIH research Whitehead Institute for Biomedical Res · Cambridge, United States · NIH-11382122

  • Stem cell and regeneration rules in planarians

    Researchers study how planarians regulate stem cells to regrow body parts, hoping to reveal ideas that could someday help human tissue repair.

    NIH research Whitehead Institute for Biomedical Res · Cambridge, United States · NIH-11349754

  • Post-transcriptional gene regulation in human cells

    A grant studying how microRNAs control which genes are turned on or off in human cells, with a focus on cancer and development.

    NIH research Whitehead Institute for Biomedical Res · Cambridge, United States · NIH-11329480

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.